Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|December 10, 2016
Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978)Chunkai Wang, Qingjie Zhao, Mireille Vargas, et al.
Prostate International|December 31, 2025
Multimodality focal therapy for prostate cancer: outcome of the <i>à la carte</i> approach in clinical practiceChi-Hang Yee, Peter K-F Chiu, Alex Q Liu, et al.
The British Journal of Dermatology|August 14, 2020
Autosomal recessive hypotrichosis with loose anagen hairs associated with TKFC mutationsA Onoufriadis, A Cabezas, J C F Ng, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 18, 2026
Cross-cultural translation into Chinese and psychometric evaluation of a screening tool for benign prostatic enlargementC F Ng, C K Chan, S K K Yuen, et al.
Frontiers in Oncology|March 15, 2021
Effectiveness of One-Stop Screening for Colorectal, Breast, and Prostate Cancers: A Population-Based Feasibility StudyJoseph J Y Sung, Arthur K C Luk, Simon S M Ng, et al.
Cell Reports. Medicine|June 4, 2026
Human primary antibody response to vaccination follows a partially sequential class-switching program with a checkpoint at IGHG2Guillem Montamat-Garcia, Joseph C F Ng, Alexander T Stewart, et al.
Acta Neurochirurgica|June 22, 2019
The importance of aspirin, catheterization accuracy, and catheter design in external ventricular drainage-related hemorrhage: a multicenter study of 1002 proceduresPeter Y M Woo, Ben C F Ng, Jacob X Xiao, et al.
The Journal of Hospital Infection|October 24, 2024
Potential use of Fourier-transform infrared spectroscopy as a rapid screening tool for investigating nosocomial outbreaks of ST-80 vancomycin-resistant Enterococcus faeciumR C W Wong, I Y Y Cheung, C K C Lai, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 17, 2026
Incidence and predictors of radiation proctitis or radiation cystitis after radiotherapy in patients with prostate cancerI C H Ko, C H T Mok, D K W Leung, et al.
Frontiers in Oncology|March 12, 2025
Treatment of metastatic castration-resistant prostate cancer: review of current evidence and synthesis of expert opinions on radioligand therapyDarren M C Poon, William S K Cheung, Peter K F Chiu, et al.
Pageof 10